← back to search

J. Antonio G. López

University of Central Florida · US
Area of research
Surgery · Immunology
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Atherosclerosis and Cardiovascular Diseases, Diabetes, Cardiovascular Risks, and Lipoproteins, and Cancer, Lipids, and Metabolism.
h-index
29
citations
4,596
works
127
NIH funding
primary concept
Medicine
email

Recent publications

Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers
JAMA Cardiology 2025cited by 28position: middledoi
Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos
Journal of the American College of Cardiology 2025cited by 5position: middledoi
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering
Journal of the American College of Cardiology 2024cited by 55position: middledoi
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
Journal of the American College of Cardiology 2024cited by 21position: middledoi
Heterogeneity of Lipoprotein(a) Levels Among Hispanic or Latino Individuals Residing in the US
JAMA Cardiology 2023cited by 21position: middledoi
Incident CHD and ischemic stroke associated with lipoprotein(a) by levels of Factor VIII and inflammation
Journal of clinical lipidology 2023cited by 12position: middledoi
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
New England Journal of Medicine 2022cited by 495position: middledoi
Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
Journal of the American Heart Association 2022cited by 29position: middledoi
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
Journal of the American College of Cardiology 2020cited by 184position: middledoi
Effects of Evolocumab on Low‐Density Lipoprotein Cholesterol, Non–High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta‐Analysis of Individual Participant Data From Double‐Blind and Open‐Label Extension Studies
Journal of the American Heart Association 2020cited by 14position: middledoi
The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy
Journal of clinical lipidology 2019cited by 53position: middledoi
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults
Journal of Lipid Research 2019cited by 14position: middledoi
Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis
Journal of clinical lipidology 2017cited by 139position: lastdoi
Visible supercontinuum generation in a graded index multimode fiber pumped at 1064  nm
Optics Letters 2016cited by 220position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert S. Rosenson · Montreal Heart Institute5 papers (2019–2024)Marc S. Sabatine · Smart Material (Germany)4 papers (2022–2025)Santica M. Marcovina · Montefiore Medical Center4 papers (2019–2025)Michelle L. O’Donoghue · Harvard University4 papers (2022–2025)You Wu · National Cancer Institute4 papers (2020–2025)Shia T. Kent · Amgen (United States)4 papers (2022–2025)Helina Kassahun · Amgen (United States)3 papers (2022–2025)Beat Knüsel · Amgen (United States)3 papers (2022–2025)Huei Wang · Amgen (United States)3 papers (2022–2025)Vera Bittner · University of Alabama at Birmingham3 papers (2019–2023)Carlos J. Rodríguez · New York University3 papers (2020–2025)Paul Muntner · Diagnostics for the Real World (United States)3 papers (2019–2023)Seth J. Baum · Clinical Trial Investigators3 papers (2022–2025)Sabina A. Murphy · Boise Bible College3 papers (2022–2025)Daniel Gaudet · Thrombolysis in Myocardial Infarction Study Group3 papers (2022–2025)Elmer Stout · CrossRoads Extremity Systems (United States)3 papers (2022–2025)Leandro Slipczuk · Twitter (United States)2 papers (2023–2025)Parag H. Joshi · Montefiore Medical Center2 papers (2023–2025)Mary Cushman · Kidney Research UK2 papers (2017–2019)Tamar Sofer · Beth Israel Deaconess Medical Center2 papers (2023–2025)